Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership with Virtua, announced plans to build a new proton facility on the campus of Virtua’s acute care hospital, Virtua Voorhees. The new $35 million center, which...
14-Dec-2017 4:40 PM EST Add to Favorites
Penn Researcher Receives $4M State Award for Multi-Institution Effort to Transform Prevention, Diagnosis, and Treatment of Traumatic Brain Injury
Douglas H. Smith, MD, the Robert A. Groff Professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania, has received a $4-million, four-year PACT (PA Consortium on Traumatic Brain Injury) award from the Pennsylvania...
14-Dec-2017 2:35 PM EST Add to Favorites
A pilot study collected physiological information from six healthy young male volunteers as they went about their normal daily lives. Thousands of indicators were measured with wearable devices and smart phone apps. The study showed the feasibility...
13-Dec-2017 1:05 PM EST Add to Favorites
Despite the fact that their disease may be more severe, a new study shows minorities are less likely than white Americans to see a doctor for psoriasis treatment. Researchers from the Perelman School of Medicine at the University of Pennsylvania...
13-Dec-2017 8:05 AM EST Add to Favorites
Pets have become an integral part of human medical research. However, a recent collaboration between Penn Med and Penn Vet has turned the tables on the arrangement.
11-Dec-2017 4:05 PM EST Add to Favorites
Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other therapies. Researchers...
8-Dec-2017 9:05 AM EST Add to Favorites
In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah™ (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin’s lymphoma (NHL) patients. Results...
7-Dec-2017 2:05 PM EST Add to Favorites
New Mediola and OlympiAD Trial Results Offer Another Boon for PARP Inhibitors in Treatment of Advanced BRCA-Related Breast Cancer
Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to two studies presented this week at the annual San Antonio Breast Cancer Symposium. Susan Domchek, MD, executive director of the...
5-Dec-2017 9:05 PM EST Add to Favorites
Penn Medicine psychology expert, Dr. Thea Gallagher available for interviews and commentary during OCD Awareness Week
5-Oct-2017 11:00 AM EDT
Penn Medicine Experts in Trauma, Mental Health, Mass Casualty, Bleeding Control, and Disaster Preparedness Available for Interviews Following Mass Shooting in Las Vegas
2-Oct-2017 11:05 AM EDT
TBI Expert Available to Discuss Chronic Traumatic Encephalopathy (CTE) and new study that found CTE in 99% of deceased NFL players' brains
25-Jul-2017 4:55 PM EDT
Penn Medicine Experts Available to Discuss the Latest Research and Treatments for Glioblastoma and Senator John McCain's Diagnosis
20-Jul-2017 10:00 AM EDT
Penn Medicine Psychologist Available to Discuss ‘Blue Whale Suicide Challenge’ and Suicide Prevention Among School-Aged Youth
19-Jul-2017 11:05 AM EDT
19-Jul-2017 11:05 AM EDT
1-Jun-2017 1:05 PM EDT
24-May-2017 12:00 PM EDT